San Jose, CA, United States of America

Guarav Abbi

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guarav Abbi. Retrieved from https://idiyas.com/inventor/guarav-abbi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guarav Abbi: Innovator in Drug Delivery Technologies

Introduction

Guarav Abbi is a notable inventor based in San Jose, California. He has made significant contributions to the field of drug delivery through his innovative methods. His work focuses on enhancing the effectiveness of in vivo drug delivery systems.

Latest Patents

Guarav Abbi holds a patent for "Methods for in vivo drug delivery with porous nanostructures." This patent describes a method of controlled drug delivery using a porous silicon matrix. The matrix is designed to trap and release a predetermined molecular complex according to a specific dose-time profile. The introduction of this matrix into the human body can occur through various methods, including transdermal introduction, intramuscular injection, intravenous introduction, surgical implantation, inhalation, and oral ingestion. He has 1 patent to his name.

Career Highlights

Guarav Abbi is affiliated with the University of California, where he continues to advance research in drug delivery technologies. His work has the potential to significantly improve therapeutic outcomes for patients.

Collaborations

He has collaborated with esteemed colleagues such as Michael J. Sailor and Boyce E. Collins, contributing to a rich environment of innovation and research.

Conclusion

Guarav Abbi's contributions to drug delivery systems exemplify the impact of innovative thinking in healthcare. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…